Xenon Pharmaceuticals Inc (XENE)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	7.50	-	-	-
Operating Expenses	17.44% 94.23	80.24	73.68	69.10	59.04
Benefits Costs and Expenses	18.32% 85.33	72.12	-	-	-
Costs And Expenses	18.32% 85.33	72.12	-	-	-
Depreciation and Amortization	4.10% 0.632	0.659	0.669	0.659	0.599
Operating Income/Loss	29.55% -94.23	-72.74	-73.68	-69.10	-59.04
Nonoperating Income/Loss	9.60% 8.897	8.118	10.57	10.85	11.52
Income/Loss From Continuing Operations Before Tax	32.05% -85.33	-64.62	-63.11	-58.26	-47.52
Income Tax Expense/Benefit, Deferred	85.99% -0.17	-1.213	-0.322	-0.333	0.403
Income Tax Expense/Benefit	246.60% -0.626	0.427	-0.32	-0.333	0.412
Income/Loss From Continuing Operations After Tax	30.22% -84.71	-65.05	-62.79	-57.92	-47.93
Net Income/Loss	30.22% -84.71	-65.05	-62.79	-57.92	-47.93
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.34% 78.95	78.69	77.93	77.67	77.59
Diluted Average Shares	0.34% 78.95	78.69	77.93	77.67	77.59
Basic Earnings Per Share	28.92% -1.07	-0.83	-0.81	-0.75	-0.62
Diluted Earnings Per Share	28.92% -1.07	-0.83	-0.81	-0.75	-0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%